AI
Thursday, October 15, 2015 12:24:17 AM
~ RGBP = HemaXellerate = IND #15376<<------
Aplastic Anemia Stem Cell Therapy – HemaXellerate – IND #15376 <<<-------------
HemaXellerate is a personalized cellular therapeutic product designed to stimulate blood production in patients whose bone marrow is not properly functioning.
Fat stem cell based product to treat bone marrow that has been damaged
Bone marrow damage occurs from radiation, chemo, or chronic conditions
HemaXellerate uses patient’s own fat as source of endothelial cells to heal damaged bone marrow
Tox studies have been completed and are awaiting analysis.
Aims to provide “natural” replacement to synthetic cytokines Synthetic cytokines that stimulate bone marrow are $18 billion market
Aplastic Anemia Stem Cell Therapy – HemaXellerate – IND #15376 <<<-------------
HemaXellerate is a personalized cellular therapeutic product designed to stimulate blood production in patients whose bone marrow is not properly functioning.
Fat stem cell based product to treat bone marrow that has been damaged
Bone marrow damage occurs from radiation, chemo, or chronic conditions
HemaXellerate uses patient’s own fat as source of endothelial cells to heal damaged bone marrow
Tox studies have been completed and are awaiting analysis.
Aims to provide “natural” replacement to synthetic cytokines Synthetic cytokines that stimulate bone marrow are $18 billion market
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
